Stonegate Investment Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $377K | Hold |
|
|||||
|
2025
Q2 | $445K | Hold |
|
|||||
|
2025
Q1 | $373K | Hold |
|
|||||
|
2024
Q4 | $374K | Buy |
|
|||||
|
2024
Q3 | $377K | Hold |
|
|||||
|
2024
Q2 | $306K | Hold |
|
|||||
|
2024
Q1 | $252K | Buy |
|
|||||
|
2023
Q4 | $293K | Hold |
|
|||||
|
2023
Q3 | $347K | Hold |
|
|||||
|
2023
Q2 | $345K | Hold |
|
|||||
|
2023
Q1 | $409K | Hold |
|
|||||
|
2022
Q4 | $562K | Hold |
|
|||||
|
2022
Q3 | $617K | Hold |
|
|||||
|
2022
Q2 | $518K | Hold |
|
|||||
|
2022
Q1 | $797K | Hold |
|
|||||
|
2021
Q4 | $678K | Buy |
|